(Q35602664)

9 August 2017

1 reference

title

Medical treatment of epilepsy. (English)

1 reference

9 August 2017

Jürgen Bauer

1

1 reference

9 August 2017

Markus Reuber

series ordinal

2

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Expert Opinion on Emerging Drugs

9 August 2017

published in

1 reference

9 August 2017

volume

8

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

457-467

1 reference

9 August 2017

cites work

New anti-epileptic drugs

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Early identification of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Neuropsychological effects of epilepsy and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

The teratogenicity of anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Anticonvulsant hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Point mutations identify the glutamate binding pocket of the N-methyl-D-aspartate receptor as major site of conantokin-G inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Structure-function relationships of the NMDA receptor antagonist conantokin peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design. Ganaxolone Presurgical Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

The antiepileptic drug losigamone decreases the persistent Na+ current in rat hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a Q.I.D. regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Talampanel, a new antiepileptic drug: single- and multiple-dose pharmacokinetics and initial 1-week experience in patients with chronic intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

Safety of intravenous valproate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.8.2.457

21 January 2018

Identifiers

DOI

10.1517/14728214.8.2.457

1 reference

9 August 2017

1 reference